Home / Inspections / 1173057

FDA Inspection 1173057 — The Procter & Gamble Manufacturing Company

The Procter & Gamble Manufacturing Company — FEI 2021299

The FDA completed an inspection of The Procter & Gamble Manufacturing Company on June 3, 2022 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 3, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Facility

Other inspections at this facility

  • 1120284 (NAI Wed Feb 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987633 (NAI Mon Aug 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 781358 (NAI Fri May 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 720198 (NAI Fri Apr 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 633906 (NAI Wed Dec 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources